Maud de Klerk-Starmans

Citée par

	Toutes	Depuis 2019
Citations	2503	1231
indice h	21	16
indice i10	28	18

300

150

225

200820092010201120122013201420152016201720182019202020212022202320248 9 12 41 38 52 124 169 209 297 277 251 233 248 201 171 127

Accès public

Tout afficher

25 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Philippe LambinProfessor of Precision Medicine, Maastricht University & Scientist ULBAdresse e-mail validée de maastrichtuniversity.nl
Paul C. BoutrosUniversity of California, Los AngelesAdresse e-mail validée de mednet.ucla.edu
Bradly WoutersPrincess Margaret Cancer Centre, University Health Network, University of TorontoAdresse e-mail validée de uhnresearch.ca
Syed HaiderThe Institute of Cancer Research, LondonAdresse e-mail validée de icr.ac.uk
Renaud SeigneuricAssociate ProfessorAdresse e-mail validée de u-bourgogne.fr
Thomas JohnMedical Oncologist, Peter MacCallum Cancer CentreAdresse e-mail validée de petermac.org
Ludwig DuboisMaastricht UniversityAdresse e-mail validée de maastrichtuniversity.nl
Francesca BuffaProfessor Computing Sciences @Bocconi University - CBIG Lab @Oxford University - AI Lab @IFOM MilanAdresse e-mail validée de unibocconi.it
Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityAdresse e-mail validée de oncology.ox.ac.uk
Ruud G.P.M. van StiphoutPrincipal Data Scientist at imec within OnePlanet Research CenterAdresse e-mail validée de imec.nl
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Adresse e-mail validée de maastro.nl
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUAdresse e-mail validée de dfci.harvard.edu
Marianne KoritzinskyUniversity of TorontoAdresse e-mail validée de uhnresearch.ca
Balaji KrishnapuramIBM Watson HealthAdresse e-mail validée de us.ibm.com
Ming TsaoUniversity of Toronto, University Health Network, Princess Margaret Cancer CentreAdresse e-mail validée de uhn.ca
Wouter van ElmptMaastricht University Medical CentreAdresse e-mail validée de maastro.nl
Cary OberijeAdresse e-mail validée de maastrichtuniversity.nl
Erik RoelofsMAASTRO Clinic, Maastricht University, GROWAdresse e-mail validée de maastro.nl
Georgi NalbantovManaging Director, Data Science Consulting Ltd.; Research Fellow at FEBA, Sofia UniversityAdresse e-mail validée de childish.ai
Glenn FungElevance HealthAdresse e-mail validée de elevancehealth.com

Suivre

Maud de Klerk-Starmans

VieCuri Medical Center

Adresse e-mail validée de viecuri.nl

Medical informatics Data science Decision Support Care Pathways


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Spatial genomic heterogeneity within localized, multifocal prostate cancer PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ... Nature genetics 47 (7), 736-745, 2015	539	2015
Predicting outcomes in radiation oncology—multifactorial decision support systems P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ... Nature reviews Clinical oncology 10 (1), 27-40, 2013	454	2013
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 5203, 2014	241	2014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 5203, 2014	241	2014
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models MW van Gisbergen, AM Voets, MHW Starmans, IFM de Coo, R Yadak, ... Mutation Research/Reviews in Mutation Research 764, 16-30, 2015	214	2015
BPG: Seamless, automated and interactive visualization of scientific data C P’ng, J Green, LC Chong, D Waggott, SD Prokopec, M Shamsi, ... BMC bioinformatics 20, 1-5, 2019	98	2019
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung … P Lambin, SF Petit, HJWL Aerts, WJC van Elmpt, CJG Oberije, ... Radiotherapy and oncology 96 (2), 145-152, 2010	91	2010
Molecular heterogeneity of non‐small cell lung carcinoma patient‐derived xenografts closely reflect their primary tumors D Wang, NA Pham, J Tong, S Sakashita, G Allo, L Kim, N Yanagawa, ... International Journal of Cancer 140 (3), 662-673, 2017	90	2017
Impact of supervised gene signatures of early hypoxia on patient survival R Seigneuric, MHW Starmans, G Fung, B Krishnapuram, DSA Nuyten, ... Radiotherapy and oncology 83 (3), 374-382, 2007	82	2007
Epigenetics in radiotherapy: Where are we heading? KM Smits, V Melotte, HEC Niessen, L Dubois, C Oberije, EGC Troost, ... Radiotherapy and Oncology 111 (2), 168-177, 2014	62	2014
The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia MBE Schaaf, D Cojocari, TG Keulers, B Jutten, MH Starmans, MC de Jong, ... Radiotherapy and Oncology 108 (3), 529-534, 2013	60	2013
A pilot study comparing HPV‐positive and HPV‐negative head and neck squamous cell carcinomas by whole exome sequencing AC Nichols, M Chan-Seng-Yue, J Yoo, W Xu, S Dhaliwal, J Basmaji, ... International Scholarly Research Notices 2012 (1), 809370, 2012	55	2012
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types MHW Starmans, B Krishnapuram, H Steck, H Horlings, DSA Nuyten, ... British journal of cancer 99 (11), 1884-1890, 2008	55	2008
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer MHW Starmans, KC Chu, S Haider, F Nguyen, R Seigneuric, ... Radiotherapy and Oncology 102 (3), 436-443, 2012	53	2012
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ... Cancer medicine 2 (6), 916-924, 2013	50	2013
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer MS Liew, J Sia, MHW Starmans, A Tafreshi, S Harris, M Feigen, S White, ... Cancer Medicine 2 (6), 916-924, 2013	50	2013
The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer T John, MHW Starmans, YT Chen, PA Russell, SA Barnett, SC White, ... PloS one 8 (7), e67876, 2013	47	2013
Pathway-based subnetworks enable cross-disease biomarker discovery S Haider, CQ Yao, VS Sabine, M Grzadkowski, V Stimper, MHW Starmans, ... Nature communications 9 (1), 4746, 2018	34	2018
Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences NS Fox, MHW Starmans, S Haider, P Lambin, PC Boutros BMC bioinformatics 15, 1-14, 2014	33	2014
Systematic analysis of ¹⁸F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors BAW Hoeben, MHW Starmans, RTH Leijenaar, LJ Dubois, ... BMC cancer 14, 1-12, 2014	27	2014

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs